Imbruvica Extends Time to Disease Worsening over Prior Regimen in MCL, Data Shows
News
The time to disease worsening or death usually shortens with each additional line of therapy, but that does not seem to be the case when the Bruton’s tyrosine kinase (BTK) inhibitor ... Read more